These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39324839)

  • 1. Surface-Functionalized Nanoceria: Dual Action in Diabetes Management via Glucose-Responsive Insulin Delivery and Oxidative Stress Mitigation.
    Sharmah B; Barman H; Afzal NU; Loying R; Kabir ME; Borah A; Das J; Kalita J; Manna P
    ACS Biomater Sci Eng; 2024 Oct; 10(10):6397-6414. PubMed ID: 39324839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High drug-loading gold nanoclusters for responsive glucose control in type 1 diabetes.
    Zhang Y; Wu M; Dai W; Chen M; Guo Z; Wang X; Tan D; Shi K; Xue L; Liu S; Lei Y
    J Nanobiotechnology; 2019 Jun; 17(1):74. PubMed ID: 31159842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-responsive hydrogel enhances the preventive effect of insulin and liraglutide on diabetic nephropathy of rats.
    Tong MQ; Luo LZ; Xue PP; Han YH; Wang LF; Zhuge DL; Yao Q; Chen B; Zhao YZ; Xu HL
    Acta Biomater; 2021 Mar; 122():111-132. PubMed ID: 33444802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
    Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
    ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold nanoclusters for controlled insulin release and glucose regulation in diabetes.
    Zhang Y; Wu M; Dai W; Li Y; Wang X; Tan D; Yang Z; Liu S; Xue L; Lei Y
    Nanoscale; 2019 Mar; 11(13):6471-6479. PubMed ID: 30892368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH and H
    Li M; Wang N; Liu R; Zhang X; He W; Zhang W; Li J; Peng C; Li Y
    Theranostics; 2024; 14(14):5596-5607. PubMed ID: 39310111
    [No Abstract]   [Full Text] [Related]  

  • 7. Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation.
    Alibolandi M; Alabdollah F; Sadeghi F; Mohammadi M; Abnous K; Ramezani M; Hadizadeh F
    J Control Release; 2016 Apr; 227():58-70. PubMed ID: 26907831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
    Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW
    J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An injectable particle-hydrogel hybrid system for glucose-regulatory insulin delivery.
    Zhao F; Wu D; Yao D; Guo R; Wang W; Dong A; Kong D; Zhang J
    Acta Biomater; 2017 Dec; 64():334-345. PubMed ID: 28974477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism.
    Deng W; Xie Q; Wang H; Ma Z; Wu B; Zhang X
    Nanomedicine; 2017 Aug; 13(6):1965-1974. PubMed ID: 28539272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
    Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly.
    Zhu JY; Lei Q; Yang B; Jia HZ; Qiu WX; Wang X; Zeng X; Zhuo RX; Feng J; Zhang XZ
    Biomaterials; 2015 Jun; 52():281-90. PubMed ID: 25818434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery.
    Li Y; Ji W; Peng H; Zhao R; Zhang T; Lu Z; Yang J; Liu R; Zhang X
    Theranostics; 2021; 11(9):4452-4466. PubMed ID: 33754071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a hydroxypropyl methyl cellulose/polyacrylic acid interpolymer complex formulated buccal mucosa adhesive film to facilitate the delivery of insulin for diabetes treatment.
    Chen Y; Zhang L; Xu J; Xu S; Li Y; Sun R; Huang J; Peng J; Gong Z; Wang J; Tang L
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):131876. PubMed ID: 38685543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an M cell targeted nanocomposite system for effective oral protein delivery: preparation, in vitro and in vivo characterization.
    Song JG; Lee SH; Han HK
    J Nanobiotechnology; 2021 Jan; 19(1):15. PubMed ID: 33422063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrilotriacetic Acid-Functionalized Glucose-Responsive Complex Micelles for the Efficient Encapsulation and Self-Regulated Release of Insulin.
    Li C; Huang F; Liu Y; Lv J; Wu G; Liu Y; Ma R; An Y; Shi L
    Langmuir; 2018 Oct; 34(40):12116-12125. PubMed ID: 30212220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of polysaccharides from natural resources to design oral insulin micro- and nanoparticles intended for the treatment of Diabetes mellitus: A review.
    Meneguin AB; Silvestre ALP; Sposito L; de Souza MPC; Sábio RM; Araújo VHS; Cury BSF; Chorilli M
    Carbohydr Polym; 2021 Mar; 256():117504. PubMed ID: 33483027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory Fucoidan-ConA oral insulin nanosystems for smart blood glucose regulation.
    Zhou J; Ma H; Guan M; Feng J; Dong X; Wei Y; Zhang T
    Int J Pharm; 2024 Jun; 659():124250. PubMed ID: 38777304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable phenylboronic acid-modified ε-polylysine for glucose-responsive insulin delivery
    Shen D; Yu H; Wang L; Chen X; Feng J; Zhang Q; Xiong W; Pan J; Han Y; Liu X
    J Mater Chem B; 2021 Aug; 9(30):6017-6028. PubMed ID: 34259305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.